APC Anti-LDL Receptor antibody [301]
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(5 Publications)
Anti-LDL Receptor antibody [301] - APC conjugated (ab275614) is a rabbit recombinant monoclonal antibody detecting LDL Receptor in Flow Cytometry. Suitable for Human.
- Recombinant format for unrivalled batch-batch consistency
View Alternative Names
Low-density lipoprotein receptor, LDL receptor, LDLR
- Flow Cyt
Supplier Data
Flow Cytometry - APC Anti-LDL Receptor antibody [301] (AB275614)
Flow cytometric analysis A431 (human epidermoid carcinoma cell line) cells labeling LDL Receptor with ab275614 at 5 μL per test (Black) compared to an isotype control (Grey).
Reactivity data
Product details
APC Anti-LDL Receptor antibody [301] (ab275614) is a rabbit recombinant monoclonal antibody and is validated for use in Flow Cytometry (Flow Cyt) in Human samples.
Related products
Antibody clone 301 is also available pre-conjugated to a variety of labels for your convenience – Anti-LDL Receptor APC [301] (ab275614).
Other related products
We have a range of other formats of antibody clone [301] also available for your convenience: APC - ab275614, Carrier free - ab276036
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The LDL receptor interacts with LDL particles to regulate cholesterol levels in the body. It is part of a cell surface complex that recognizes and binds to apolipoprotein B-100 or apolipoprotein E present on LDL. This interaction initiates internalization of LDL leading to its degradation in lysosomes where cholesterol can be released and used by the cell. Mutations in the gene encoding LDLR can lead to inefficient cholesterol uptake influencing various metabolic processes.
Pathways
LDL receptor activities are integral to lipid metabolism and cholesterol homeostasis. Two important biological pathways that involve LDLR include the cholesterol biosynthesis pathway and the lipoprotein clearance pathway. Within these pathways LDLR collaborates closely with proteins like PCSK9 which modulates its expression and degradation and HMG-CoA reductase an important enzyme in cholesterol synthesis to balance cholesterol levels in the body.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (5)
Recent publications for all applications. Explore the full list and refine your search
Molecular genetics & genomic medicine 12:e70030 PubMed39600113
2024
Applications
Unspecified application
Species
Unspecified reactive species
Scientific reports 14:15592 PubMed38971841
2024
Applications
Unspecified application
Species
Unspecified reactive species
Lipids in health and disease 23:85 PubMed38515137
2024
Applications
Unspecified application
Species
Unspecified reactive species
Lipids in health and disease 22:77 PubMed37340302
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of cellular biochemistry 122:1791-1804 PubMed34397115
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com